<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32462331</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>08</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1534-6293</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>Current neurology and neuroscience reports</Title><ISOAbbreviation>Curr Neurol Neurosci Rep</ISOAbbreviation></Journal><ArticleTitle>Sleep and Sleep Disruption in Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>25</StartPage><MedlinePgn>25</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">25</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11910-020-01047-1</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">In amyotrophic lateral sclerosis (ALS), sleep disruption is frequently present and substantially adds to disease burden. This review aims to summarize current knowledge on causes, pathophysiology, and treatment of sleep disturbances in ALS.</AbstractText><AbstractText Label="RECENT FINDINGS">Motor neuron degeneration and muscle weakness may lead to muscle cramps, pain, spasticity, immobilization, restless legs, sleep-disordered breathing, and difficulties to clear secretions. Furthermore, existential fears and depression may promote insomnia. Sleep-disordered breathing, and nocturnal hypoventilation in particular, requires ventilatory support which meaningfully prolongs survival and improves health-related quality of life albeit respiratory failure is inevitable. Early indication for non-invasive ventilation can be achieved by inclusion of capnometry in diagnostic sleep studies. Sleep disruption is extremely common in ALS and may arise from different etiologies. The absence of causative therapeutic options for ALS underlines the importance of symptomatic and palliative treatment strategies that acknowledge sleep-related complaints.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boentert</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6133-1397</Identifier><AffiliationInfo><Affiliation>Department of Neurology with Institute of Translational Neurology, University Hospital M&#xfc;nster (UKM), Albert-Schweitzer-Campus 1, Building A1, 48149, M&#xfc;nster, Germany. matthias.boentert@ukmuenster.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, UKM Marienhospital Steinfurt, Steinfurt, Germany. matthias.boentert@ukmuenster.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Neurol Neurosci Rep</MedlineTA><NlmUniqueID>100931790</NlmUniqueID><ISSNLinking>1528-4042</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017286" MajorTopicYN="N">Polysomnography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012890" MajorTopicYN="N">Sleep</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Insomnia</Keyword><Keyword MajorTopicYN="N">Sleep</Keyword><Keyword MajorTopicYN="N">Sleep-disordered breathing</Keyword></KeywordList><CoiStatement>The author declares that he has no competing interests in the context of this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32462331</ArticleId><ArticleId IdType="pmc">PMC7253511</ArticleId><ArticleId IdType="doi">10.1007/s11910-020-01047-1</ArticleId><ArticleId IdType="pii">10.1007/s11910-020-01047-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grad LI, Rouleau GA, Ravits J, Cashman NR. Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med. 2017;7:a024117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5538408</ArticleId><ArticleId IdType="pubmed">28003278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakken O, Lindstrom JC, Tysnes OB, Holmoy T. Assessing amyotrophic lateral sclerosis prevalence in Norway from 2009 to 2015 from compulsory nationwide health registers. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(3&#x2013;4):303&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">29271248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kab S, Moisan F, Preux PM, Marin B, Elbaz A. Nationwide incidence of motor neuron disease using the French health insurance information system database. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(5&#x2013;6):426&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">28387141</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbohm A, Peter RS, Erhardt S, Lule D, Rothenbacher D, Ludolph AC, et al. Epidemiology of amyotrophic lateral sclerosis in Southern Germany. J Neurol. 2017;264(4):749&#x2013;757.</Citation><ArticleIdList><ArticleId IdType="pubmed">28220290</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragonese P, Cellura E, Aridon P, D'Amelio M, Spataro R, Taiello AC, et al. Incidence of amyotrophic lateral sclerosis in Sicily: a population based study. Amyotroph Lateral Scler. 2012;13(3):284&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pubmed">22409362</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R, et al. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology. 2009;72(8):725&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">19237701</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A, Logroscino G, Jick SS, Hernan MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol. 2009;16(6):745&#x2013;751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3093130</ArticleId><ArticleId IdType="pubmed">19475756</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster LA, Salajegheh MK. Motor neuron disease: pathophysiology, diagnosis, and management. Am J Med. 2019;132(1):32&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">30075105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacomblez L, Bensimon G, Leigh PN, Guillet P, Powe L, Durrleman S, et al. A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II. Neurology. 1996;47(6 Suppl 4):S242&#x2013;S250.</Citation><ArticleIdList><ArticleId IdType="pubmed">8959996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 1996;347(9013):1425&#x2013;1431.</Citation><ArticleIdList><ArticleId IdType="pubmed">8676624</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994;330(9):585&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Group On Behalf Of The Edaravone ALS Study Group Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: grade 3, requiring assistance for eating, excretion or ambulation) Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:40&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">28872915</ArticleId></ArticleIdList></Reference><Reference><Citation>Takei K, Takahashi F, Liu S, Tsuda K, Palumbo J. Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(sup1):49&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">28872913</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur J Neurol. 2012;19(3):360&#x2013;75. This guideline document outlines all issues that are relevant for pharmacological, symptomatic, and palliative treatment of ALS.</Citation><ArticleIdList><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Traxinger K, Kelly C, Johnson BA, Lyles RH, Glass JD. Prognosis and epidemiology of amyotrophic lateral sclerosis: analysis of a clinic population, 1997-2011. Neurol Clin Pract. 2013;3(4):313&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3787117</ArticleId><ArticleId IdType="pubmed">24195020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2008;79(1):33&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17550991</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A, Moglia C, Lunetta C, Marinou K, Ticozzi N, Ferrante GD, et al. Factors predicting survival in ALS: a multicenter Italian study. J Neurol. 2017;264(1):54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">27778156</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R, Lo Re M, Piccoli T, Piccoli F, La Bella V. Causes and place of death in Italian patients with amyotrophic lateral sclerosis. Acta Neurol Scand. 2010;122(3):217&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">20078446</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil J, Funalot B, Verschueren A, Danel-Brunaud V, Camu W, Vandenberghe N, et al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol. 2008;15(11):1245&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">18973614</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke SC, McColl E, Shaw PJ, Gibson GJ. Validation of quality of life instruments in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(1):55&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">15204025</ArticleId></ArticleIdList></Reference><Reference><Citation>Bromberg MB. Quality of life in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am. 2008;19(3):591&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">18625418</ArticleId></ArticleIdList></Reference><Reference><Citation>Epton J, Harris R, Jenkinson C. Quality of life in amyotrophic lateral sclerosis/motor neuron disease: a structured review. Amyotroph Lateral Scler. 2009;10(1):15&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">18752087</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke T, Galvin M, Pinto-Grau M, Lonergan K, Madden C, Mays I, et al. Caregivers of patients with amyotrophic lateral sclerosis: investigating quality of life, caregiver burden, service engagement, and patient survival. J Neurol. 2017;264(5):898&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pubmed">28280986</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja D, Stephens HE, Lehman E, Walsh S, Yang C, Simmons Z. Patient-reported problematic symptoms in an ALS treatment trial. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3&#x2013;4):198&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4979603</ArticleId><ArticleId IdType="pubmed">26824413</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda S, Gourie-Devi M, Sharma A. Sleep disorders in amyotrophic lateral sclerosis: a questionnaire-based study from India. Neurol India. 2018;66(3):700&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">29766929</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Coco D, La Bella V. Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2012;19(5):760&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pubmed">22233269</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Coco D, Mattaliano P, Spataro R, Mattaliano A, La Bella V. Sleep-wake disturbances in patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82(8):839&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pubmed">21217159</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Abad M, Buczyner JR, Venza BR, Scharf SM, Kwan JY, Lubinski B, et al. Poor sleep quality in patients with amyotrophic lateral sclerosis at the time of diagnosis. J Clin Neuromuscul Dis. 2018;20(2):60&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30439751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Newcombe RE, Piper AJ, Lewis SJ, Yee BJ, Kiernan MC, et al. Sleep disorders and respiratory function in amyotrophic lateral sclerosis. Sleep Med Rev. 2016;26:33&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">26166297</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagna P, Liguori R, Zucconi M, Lugaresi A, Cirignotta F, Lugaresi E. Fasciculations during wakefulness and sleep. Acta Neurol Scand. 1987;76(2):152&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">3673501</ArticleId></ArticleIdList></Reference><Reference><Citation>American Academy of Sleep Medicine. International classification of sleep disorders: American Academy of Sleep Medicine. 2014.</Citation></Reference><Reference><Citation>Caress JB, Ciarlone SL, Sullivan EA, Griffin LP, Cartwright MS. Natural history of muscle cramps in amyotrophic lateral sclerosis. Muscle Nerve. 2016;53(4):513&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775451</ArticleId><ArticleId IdType="pubmed">26332705</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldissera F, Cavallari P, Dworzak F. Motor neuron &#x2018;bistability&#x2019;. A pathogenetic mechanism for cramps and myokymia. Brain. 1994;117(Pt 5):929&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">7953602</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B, Moore D, Mozaffar T, Ravits J, Wiedau-Pazos M, Parziale N, et al. Mexiletine for muscle cramps in amyotrophic lateral sclerosis: a randomized, double-blind crossover trial. Muscle Nerve. 2018;58:42&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6126993</ArticleId><ArticleId IdType="pubmed">29510461</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldinger R, Katzberg HD, Weber M. Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2012;4:CD004157.</Citation><ArticleIdList><ArticleId IdType="pubmed">22513921</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Tawil S, Al Musa T, Valli H, Lunn MP, Brassington R, El-Tawil T, et al. Quinine for muscle cramps. Cochrane Database Syst Rev. 2015;4:CD005044.</Citation><ArticleIdList><ArticleId IdType="pubmed">25842375</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan DB. Quinine: not a safe drug for treating nocturnal leg cramps. CMAJ. 2015;187(4):237&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4347765</ArticleId><ArticleId IdType="pubmed">25623647</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T, Narita Y, Okugawa N, Hamaguchi E, Shibahara M, Kuzuhara S. Pressure ulcers in ALS patients on admission at a university hospital in Japan. Amyotroph Lateral Scler. 2007;8(5):310&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">17852025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono S, Toyokura Y, Mannen T, Ishibashi Y. Increased dermal collagen density in amyotrophic lateral sclerosis. J Neurol Sci. 1988;83(1):81&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">3346711</ArticleId></ArticleIdList></Reference><Reference><Citation>Abetz L, Allen R, Follet A, Washburn T, Earley C, Kirsch J, et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther. 2004;26(6):925&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">15262463</ArticleId></ArticleIdList></Reference><Reference><Citation>Limousin N, Blasco H, Corcia P, Arnulf I, Praline J. The high frequency of restless legs syndrome in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12(4):303&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">21314298</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Shen D, Tai H, Su N, Ding Q, Fu H, et al. Restless legs syndrome in Chinese patients with sporadic amyotrophic lateral sclerosis. Front Neurol. 2018;9:735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6125374</ArticleId><ArticleId IdType="pubmed">30214425</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Coco D, Piccoli F, La Bella V. Restless legs syndrome in patients with amyotrophic lateral sclerosis. Mov Disord. 2010;25(15):2658&#x2013;2661.</Citation><ArticleIdList><ArticleId IdType="pubmed">20669314</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla Bella E, Lombardi R, Porretta-Serapiglia C, Ciano C, Gellera C, Pensato V, et al. Amyotrophic lateral sclerosis causes small fiber pathology. Eur J Neurol. 2016;23(2):416&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">26806218</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis J, Katona I, Muller-Newen G, Sommer C, Necula G, Hendrich C, et al. Small-fiber neuropathy in patients with ALS. Neurology. 2011;76(23):2024&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21646630</ArticleId></ArticleIdList></Reference><Reference><Citation>Isak B, Tankisi H, Johnsen B, Pugdahl K, Torvin MA, Finnerup NB, et al. Involvement of distal sensory nerves in amyotrophic lateral sclerosis. Muscle Nerve. 2016;54(6):1086&#x2013;1092.</Citation><ArticleIdList><ArticleId IdType="pubmed">27104485</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Borreguero D, Silber MH, Winkelman JW, Hogl B, Bainbridge J, Buchfuhrer M, et al. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med. 2016;21:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">27448465</ArticleId></ArticleIdList></Reference><Reference><Citation>Puligheddu M, Congiu P, Arico D, Rundo F, Borghero G, Marrosu F, et al. Isolated rapid eye movement sleep without atonia in amyotrophic lateral sclerosis. Sleep Med. 2016;26:16&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">28007355</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Coco D, Puligheddu M, Mattaliano P, Congiu P, Borghero G, Fantini ML, et al. REM sleep behavior disorder and periodic leg movements during sleep in ALS. Acta Neurol Scand. 2017;135(2):219&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">27027974</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Boentert M, Glatz C, Helmle C, Okegwo A, Young P. Prevalence of sleep apnoea and capnographic detection of nocturnal hypoventilation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2018;89(4):418&#x2013;24. This large retrospective study proves that transcutaneous capnometry is superior to pulse oximetry for detection of sleep-related hypoventilation.</Citation><ArticleIdList><ArticleId IdType="pubmed">29054915</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyhani A, Benbir Senel G, Karadeniz D. Effects of sleep-related disorders on the prognosis of amyotrophic lateral sclerosis. Neurodegener Dis. 2020:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32114585</ArticleId></ArticleIdList></Reference><Reference><Citation>Bara-Jimenez W, Aksu M, Graham B, Sato S, Hallett M. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology. 2000;54(8):1609&#x2013;1616.</Citation><ArticleIdList><ArticleId IdType="pubmed">10762502</ArticleId></ArticleIdList></Reference><Reference><Citation>Finan PH, Goodin BR, Smith MT. The association of sleep and pain: an update and a path forward. J Pain. 2013;14(12):1539&#x2013;1552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046588</ArticleId><ArticleId IdType="pubmed">24290442</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheatle MD, Foster S, Pinkett A, Lesneski M, Qu D, Dhingra L. Assessing and managing sleep disturbance in patients with chronic pain. Sleep Med Clin. 2016;11(4):531&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">28118876</ArticleId></ArticleIdList></Reference><Reference><Citation>Moisset X, Cornut-Chauvinc C, Clavelou P, Pereira B, Dallel R, Guy N. Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study. Palliat Med. 2016;30(5):486&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">26269326</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Wallace VC, Ellis CM, Burman R, Knights C, Shaw CE, Al-Chalabi A. The evaluation of pain in amyotrophic lateral sclerosis: a case controlled observational study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7&#x2013;8):520&#x2013;7. This study outlines the epidemiology and clinical determinants of chronic pain in patients with ALS.</Citation><ArticleIdList><ArticleId IdType="pubmed">25204842</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J, Torres-Cueco R, van Wilgen CP, Girbes EL, Struyf F, Roussel N, et al. Applying modern pain neuroscience in clinical practice: criteria for the classification of central sensitization pain. Pain Physician. 2014;17(5):447&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">25247901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler EA, Magerl W, Meyer RA, Treede RD. Secondary hyperalgesia to punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input. Brain. 1999;122(Pt 12):2245&#x2013;2257.</Citation><ArticleIdList><ArticleId IdType="pubmed">10581220</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Mora G, Lauria G. Pain in amyotrophic lateral sclerosis. Lancet Neurol. 2017;16(2):144&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">27964824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganzini L, Silveira MJ, Johnston WS. Predictors and correlates of interest in assisted suicide in the final month of life among ALS patients in Oregon and Washington. J Pain Symptom Manag. 2002;24(3):312&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">12458112</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson KA, Strong MJ, Ahmad D, George CF. Sleep-disordered breathing in amyotrophic lateral sclerosis. Chest. 1996;110(3):664&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pubmed">8797409</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos C, Braghiroli A, Mazzini L, Pratesi R, Oliveira LV, Mora G. Sleep-related breathing disorders in amyotrophic lateral sclerosis. Monaldi Arch Chest Dis. 2003;59(2):160&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">14635507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124(Pt 10):2000&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">11571218</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaranta VN, Carratu P, Damiani MF, Dragonieri S, Capozzolo A, Cassano A, et al. The prognostic role of obstructive sleep apnea at the onset of amyotrophic lateral sclerosis. Neurodegener Dis. 2017;17(1):14&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">27595268</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger KI, Rapoport DM, Ayappa I, Goldring RM. Pathophysiology of hypoventilation during sleep. Sleep Med Clin. 2014;9:289&#x2013;300.</Citation></Reference><Reference><Citation>Boentert M, Brenscheidt I, Glatz C, Young P. Effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with amyotrophic lateral sclerosis. J Neurol. 2015;262(9):2073&#x2013;2082.</Citation><ArticleIdList><ArticleId IdType="pubmed">26076745</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzberg HD, Selegiman A, Guion L, Yuan N, Cho SC, Katz JS, et al. Effects of noninvasive ventilation on sleep outcomes in amyotrophic lateral sclerosis. J Clin Sleep Med. 2013;9(4):345&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3601313</ArticleId><ArticleId IdType="pubmed">23585750</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrijsen B, Buyse B, Belge C, Robberecht W, Van Damme P, Decramer M, et al. Noninvasive ventilation improves sleep in amyotrophic lateral sclerosis: a prospective polysomnographic study. J Clin Sleep Med. 2015;11(5):559&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4410930</ArticleId><ArticleId IdType="pubmed">25766713</ArticleId></ArticleIdList></Reference><Reference><Citation>David WS, Bundlie SR, Mahdavi Z. Polysomnographic studies in amyotrophic lateral sclerosis. J Neurol Sci. 1997;152(Suppl 1):S29&#x2013;S35.</Citation><ArticleIdList><ArticleId IdType="pubmed">9419051</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnulf I, Similowski T, Salachas F, Garma L, Mehiri S, Attali V, et al. Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2000;161(3 Pt 1):849&#x2013;856.</Citation><ArticleIdList><ArticleId IdType="pubmed">10712332</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogna A, Quera Salva MA, Prigent H, Mroue G, Vaugier I, Annane D, et al. Nocturnal hypoventilation in neuromuscular disease: prevalence according to different definitions issued from the literature. Sleep Breath. 2016;20(2):575&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">26338464</ArticleId></ArticleIdList></Reference><Reference><Citation>Barthlen GM, Lange DJ. Unexpectedly severe sleep and respiratory pathology in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2000;7(3):299&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">10886313</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitting JW, Paillex R, Hirt L, Aebischer P, Schluep M. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol. 1999;46(6):887&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pubmed">10589541</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171(3):269&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">15516537</ArticleId></ArticleIdList></Reference><Reference><Citation>Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry. 2006;77(3):390&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2077717</ArticleId><ArticleId IdType="pubmed">16484652</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Tilanus TBM, Groothuis JT, Tenbroek-Pastoor JMC, Feuth TB, Heijdra YF, Slenders JPL, et al. The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis. Respir Res. 2017;18(1):144. This study nicely investigates which bedside tests of respiratory muscle strength are suitable to predict nocturnal hypoventilation and the need for non-invasive ventilatory support in ALS patients.</Citation></Reference><Reference><Citation>Carratu P, Cassano A, Gadaleta F, Tedone M, Dongiovanni S, Fanfulla F, et al. Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: preliminary results. Amyotroph Lateral Scler. 2011;12(6):458&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">21745123</ArticleId></ArticleIdList></Reference><Reference><Citation>Windisch W, Dreher M, Geiseler J, Siemon K, Brambring J, Dellweg D, et al. Guidelines for non-invasive and invasive home mechanical ventilation for treatment of chronic respiratory failure - update 2017. Pneumologie. 2017;71(11):722&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">29139100</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackrivo J, Hansen-Flaschen J, Jones BL, Wileyto EP, Schwab RJ, Elman L, et al. Classifying patients with amyotrophic lateral sclerosis by changes in FVC. A group-based trajectory analysis. Am J Respir Crit Care Med. 2019;200(12):1513&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909832</ArticleId><ArticleId IdType="pubmed">31322417</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Ackrivo J, Hansen-Flaschen J, Wileyto EP, Schwab RJ, Elman L, Kawut SM. Development of a prognostic model of respiratory insufficiency or death in amyotrophic lateral sclerosis. Eur Respir J. 2019;53(4):1802237. This large study provides an evidence-based approach for prognostication of respiratory insufficiency in ALS.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6684229</ArticleId><ArticleId IdType="pubmed">30728207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bote SM, Martinez NP, Amarilla CE, Ugalde PF, Gonzalez-Bermejo J, Collado NF, et al. Overnight pulse oximetry to determine prognostic factors in subjects with amyotrophic lateral sclerosis. Respir Care. 2020;respcare.07154. 10.4187/respcare.07154.</Citation><ArticleIdList><ArticleId IdType="pubmed">32184376</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboussouan LS, Khan SU, Banerjee M, Arroliga AC, Mitsumoto H. Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve. 2001;24(3):403&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">11353427</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboussouan LS, Khan SU, Meeker DP, Stelmach K, Mitsumoto H. Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med. 1997;127(6):450&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pubmed">9313002</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach JR. Amyotrophic lateral sclerosis: predictors for prolongation of life by noninvasive respiratory aids. Arch Phys Med Rehabil. 1995;76(9):828&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pubmed">7668953</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach JR. Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory AIDS. Chest. 2002;122(1):92&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">12114343</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertella E, Banfi P, Paneroni M, Grilli S, Bianchi L, Volpato E, et al. Early initiation of night-time NIV in an outpatient setting: a randomized non-inferiority study in ALS patients. Eur J Phys Rehabil Med. 2017;53(6):892&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28382811</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. The Lancet Neurology. 2006;5(2):140&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">16426990</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt C, Neuwirth C, Sommacal A, Andersen PM, Weber M. Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients. PLoS One. 2017;12(5):e0177555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5441602</ArticleId><ArticleId IdType="pubmed">28542233</ArticleId></ArticleIdList></Reference><Reference><Citation>Butz M, Wollinsky KH, Wiedemuth-Catrinescu U, Sperfeld A, Winter S, Mehrkens HH, et al. Longitudinal effects of noninvasive positive-pressure ventilation in patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2003;82(8):597&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">12872016</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Calvo A, Moglia C, Gamna F, Mattei A, Mazzini L, et al. Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study. J Neurol Neurosurg Psychiatry. 2012;83(4):377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">22013242</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin EM, Wilson CS, Sriaroon C, Crudup B, Pothen S, Kang YC, et al. Effects of early introduction of non-invasive positive pressure ventilation based on forced vital capacity rate of change: variation across amyotrophic lateral sclerosis clinical phenotypes. Int J Clin Pract. 2019;73(1):e13257.</Citation><ArticleIdList><ArticleId IdType="pubmed">30230161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999;164(1):82&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">10385053</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto AC, Evangelista T, Carvalho M, Alves MA, Sales Luis ML. Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial. J Neurol Sci. 1995;129(Suppl):19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">7595610</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivori M, Rodriguez GE, Pascansky D, Saenz C, Sica RE. Outcome of sporadic amyotrophic lateral sclerosis treated with non-invasive ventilation and riluzole. Medicina. 2007;67(4):326&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pubmed">17891927</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Vitacca M, Montini A, Lunetta C, Banfi P, Bertella E, De Mattia E, et al. Impact of an early respiratory care programme with non-invasive ventilation adaptation in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25(3):556&#x2013;e33. This large retrospective study supports the notion that non-invasive ventilation has substantial prognostic impact in ALS patients with both spinal and bulbar onset of disease.</Citation><ArticleIdList><ArticleId IdType="pubmed">29266547</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne E, Vrijsen B, Belge C, Testelmans D, Buyse B. Noninvasive ventilation in amyotrophic lateral sclerosis: effects on sleep quality and quality of life. Acta Clin Belg. 2016;71(6):389&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">27112318</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustfa N, Walsh E, Bryant V, Lyall RA, Addington-Hall J, Goldstein LH, et al. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology. 2006;66(8):1211&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16636239</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyall RA, Donaldson N, Fleming T, Wood C, Newsom-Davis I, Polkey MI, et al. A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology. 2001;57(1):153&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445650</ArticleId></ArticleIdList></Reference><Reference><Citation>Teschler H, Stampa J, Ragette R, Konietzko N, Berthon-Jones M. Effect of mouth leak on effectiveness of nasal bilevel ventilatory assistance and sleep architecture. Eur Respir J. 1999;14(6):1251&#x2013;1257.</Citation><ArticleIdList><ArticleId IdType="pubmed">10624751</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellhas V, Glatz C, Beecken I, Okegwo A, Heidbreder A, Young P, et al. Upper airway obstruction induced by non-invasive ventilation using an oronasal interface. Sleep Breath. 2018;22(3):781&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29453639</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Sancho J, Bures E, Ferrer S, Ferrando A, Banuls P, Servera E. Unstable control of breathing can lead to ineffective noninvasive ventilation in amyotrophic lateral sclerosis. ERJ Open Res. 2019;5(3):00099-2019. As a novelty, this study shows that central breathing control during sleep may be altered in ALS.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6646962</ArticleId><ArticleId IdType="pubmed">31360697</ArticleId></ArticleIdList></Reference><Reference><Citation>Sancho J, Servera E, Morelot-Panzini C, Salachas F, Similowski T, Gonzalez-Bermejo J. Non-invasive ventilation effectiveness and the effect of ventilatory mode on survival in ALS patients. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(1&#x2013;2):55&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">24266679</ArticleId></ArticleIdList></Reference><Reference><Citation>Georges M, Attali V, Golmard JL, Morelot-Panzini C, Crevier-Buchman L, Collet JM, et al. Reduced survival in patients with ALS with upper airway obstructive events on non-invasive ventilation. J Neurol Neurosurg Psychiatry. 2016;87(10):1045&#x2013;1050.</Citation><ArticleIdList><ArticleId IdType="pubmed">27090433</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Bermejo J, Morelot-Panzini C, Arnol N, Meininger V, Kraoua S, Salachas F, et al. Prognostic value of efficiently correcting nocturnal desaturations after one month of non-invasive ventilation in amyotrophic lateral sclerosis: a retrospective monocentre observational cohort study. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(5&#x2013;6):373&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23527531</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogna A, Nardi J, Prigent H, Quera Salva MA, Chaffaut C, Lamothe L, et al. Prognostic value of initial assessment of residual hypoventilation using nocturnal capnography in mechanically ventilated neuromuscular patients: a 5-year follow-up study. Front Med (Lausanne) 2016;3:40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5020068</ArticleId><ArticleId IdType="pubmed">27679799</ArticleId></ArticleIdList></Reference><Reference><Citation>Sancho J, Martinez D, Bures E, Diaz JL, Ponz A, Servera E. Bulbar impairment score and survival of stable amyotrophic lateral sclerosis patients after noninvasive ventilation initiation. ERJ Open Res. 2018;4(2):00159-2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5900060</ArticleId><ArticleId IdType="pubmed">29670892</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitacca M, Paneroni M, Trainini D, Bianchi L, Assoni G, Saleri M, et al. At home and on demand mechanical cough assistance program for patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2010;89(5):401&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20407305</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustfa N, Aiello M, Lyall RA, Nikoletou D, Olivieri D, Leigh PN, et al. Cough augmentation in amyotrophic lateral sclerosis. Neurology. 2003;61(9):1285&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">14610141</ArticleId></ArticleIdList></Reference><Reference><Citation>Luppi PH, Clement O, Sapin E, Gervasoni D, Peyron C, Leger L, et al. The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder. Sleep Med Rev. 2011;15(3):153&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">21115377</ArticleId></ArticleIdList></Reference><Reference><Citation>Iranzo A, Fernandez-Arcos A, Tolosa E, Serradell M, Molinuevo JL, Valldeoriola F, et al. Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. PLoS One. 2014;9(2):e89741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3935943</ArticleId><ArticleId IdType="pubmed">24587002</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeve BF, Silber MH, Ferman TJ, Lin SC, Benarroch EE, Schmeichel AM, et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013;14(8):754&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3745815</ArticleId><ArticleId IdType="pubmed">23474058</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagnin A, Mariotto S, Fiorini M, Gaule M, Bonetto N, Tagliapietra M, et al. Microglial and neuronal TDP-43 pathology in anti-IgLON5-related tauopathy. J Alzheimers Dis. 2017;59(1):13&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">28550263</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Coco D, Caruso G, Mattaliano A. REM sleep behavior disorder in patients with DJ-1 mutations and parkinsonism-dementia-ALS complex. Mov Disord. 2009;24(10):1555&#x2013;1556.</Citation><ArticleIdList><ArticleId IdType="pubmed">19441133</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Coco D, Cupidi C, Mattaliano A, Baiamonte V, Realmuto S, Cannizzaro E. REM sleep behavior disorder in a patient with frontotemporal dementia. Neurol Sci. 2012;33(2):371&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pubmed">21751100</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebben MR, Shahbazi M, Lange DJ, Krieger AC. REM behavior disorder associated with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13(5):473&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">22670878</ArticleId></ArticleIdList></Reference><Reference><Citation>Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135(1&#x2013;3):10&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21300408</ArticleId></ArticleIdList></Reference><Reference><Citation>Skapinakis P, Rai D, Anagnostopoulos F, Harrison S, Araya R, Lewis G. Sleep disturbances and depressive symptoms: an investigation of their longitudinal association in a representative sample of the UK general population. Psychol Med. 2013;43(2):329&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">22640482</ArticleId></ArticleIdList></Reference><Reference><Citation>Congiu P, Mariani S, Milioli G, Parrino L, Tamburrino L, Borghero G, et al. Sleep cardiac dysautonomia and EEG oscillations in amyotrophic lateral sclerosis. Sleep. 2019;42(11):zsz164.</Citation><ArticleIdList><ArticleId IdType="pubmed">31312838</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>